Beth Fand Incollingo

AN ANTIOXIDANT APPROVED FOR use as an antidote to cyanide poisoning may also prevent hearing loss, a potential side effect of the chemotherapy drug cisplatin, in children who take the anticancer drug.

Through a new program run by the nonprofit organization Count Me In, patients with cancer in the United States and Canada can share their medical information, personal experiences and tumor samples with researchers worldwide, who will use the information in studies without revealing patient names.

The New York City chef dreamed of opening her own restaurant.

Immunotherapy has become a buzzword in the cancer community, but to Sean Parker it’s much more. The 39-year-old billionaire is intensely focused on the promise of immunotherapy, and has become a major force in helping to drive its potential to cure cancers.

Researchers have taught computer to analyze lung cancer tissue and distinguish between the two most common types of the disease — adenocarcinoma and squamous cell — with an accuracy of more than 90 percent.

One specialist debunks the most common myths about chronic lymphocytic leukemia and its treatment.

PAUL ALLEN, A COFOUNDER of Microsoft, died of the blood cancer non-Hodgkin lymphoma on Oct. 16.

Comedian Maria Falzone, who is also a lecturer on safer sex, is living in the moment as she faces her final months with advanced bile duct cancer. She told CURE® why she sees her cancer as a gift.

Measuring circulating tumor DNA in the blood of patients with advanced mantle cell lymphoma may be a viable way to predict how well they will respond to specific therapies.

Treatment with Velcade (bortezomib) following induction chemotherapy and stem cell transplantation seemed safe and effective for untreated patients with mantle cell lymphoma, encouraging further evaluation for more active, less toxic targeted agents.

A recent study looked at a new combination to determine what would happen if untreated patients eligible for transplant were given alternating cycles of Rituxan plus bendamustine and Rituxan plus cytarabine as induction therapy. The study pooled findings from two clinical trials and real-world experience.

An oncologist and three advocates were honored for their work on behalf of people with chronic lymphocytic leukemia.

A retrospective study found that clinical trials may have fewer reported side effects than the real world.

At the MPN Heroes Event, Olympic skater Scott Hamilton discusses importance of advocacy and research.

What’s the best plan for lowering cancer drug prices? A panel of experts debated the possibilities.

Chronic lymphocytic leukemia can now be managed as a long-term condition, and there are new ways loved ones can help.

A clinical trial will test a radiation regimen designed to preserve sexual function in men being treated for prostate cancer.

People with slow-growing B-cell lymphomas and no symptoms are often prescribed a watch-and-wait approach, which involves monitoring until the disease grows and warrants treatment.

In a new book of poetry, Kari Wergeland describes key recollections and insights from her journey with breast cancer.

From an inaugural gathering in 2009 that attracted approximately 700 people, the Life and Liberty event has grown in size each year, with more than 4,000 patients in attendance at last September’s celebration. Organizers said about 6,000 were there this year.

Team physician James Muntz diagnosed the blood cancer, and Hal then consulted with oncologists at The University of Texas MD Anderson Cancer Center in Houston.

The wigs resemble the hair of Disney princesses, and though most are designed for girls ages 2 to 10, there are a few styles for boys.

Robin Roberts discusses her two cancer journeys and why she shared them with viewers of 'Good Morning America.'

Better treatment options have put chronic lymphocytic leukemia in the spotlight in recent years. But just what is CLL?

An Idaho teenager a boost from one of her idols — former Vice President Joe Biden — during her treatment for acute myeloid leukemia.

The 68-year-old explained that he’d had a tumor removed from his abdomen, followed by complications and then the return of aggressive cancer. He did not specify its subtype.

The speakers noted that certain well-known cancer centers are highly sought by organizations planning trials, due to their success at enrolling participants. That breeds competition among the hosts of trials to work with those centers and enroll their patients, which is detrimental to the pace of research overall.

Stand Up To Cancer’s “interception” trials tackle lung and pancreatic disease early, with the goal of preventing progression to advanced stages.

In melanoma, combining two immunotherapies may lower costs and improve quality of life.

We sat down with oncology nurse Christine Stone, M.S.N., RN, OCN, winner of this year's Extraordinary Healer award, to hear about the impact she makes on her patients with cancer.